AIRR - ANZCA Institutional Research Repository
Skip navigation

The SNAPP Pilot Study: Suggamedex, Neostigimine and Postoperative Pulmonary Complications


Grant Title
The SNAPP Pilot Study: Suggamedex, Neostigimine and Postoperative Pulmonary Complications
 
Chief Investigator/s
 
Administering Institution/s
The University of Melbourne
 
ANZCA Area of Research
Anaesthesia
 
Project Summary
The SNaPP Study is a large (n=3,500) four year, multicentre, double-blind, randomised clinical trial examining the effect of reversal of neuromuscular blockade on postoperative outcomes.

Adult patients having abdominal or thoracic surgery under relaxant general anaesthesia with an endotracheal tube will be randomised to sugammadex or neostigmine for reversal of neuromuscular blockade. The primary outcome is a composite of death or postoperative pulmonary complications up to hospital discharge (or postoperative day 7 if still in hospital).

The team from the University of Melbourne is led by Professor Kate Leslie AO FAHMS. The trial is funded by a $2.9 million grant from the Medical Research Future Fund. Please email Sofia Sidiropoulos if you are interested in being involved or would like further information about the SNaPP Study.
 
Grant Type
CTN Pilot
 
CTN Endorsed Study
Yes
 
Funding Year
2020
 
Funding Amount
$2.9 million grant from the Medical Research Future Fund
 
 
Status
In Progress

Publications
(All)

Results 1-1 of 1 (Search time: 0.002 seconds).